Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6867072 | 1.00 | ALDH1A1 (0.41) | ALDH1A1GAANPSR1CASP1MAPT | |
| SCHEMBL6866892 | 0.86 | ALDH1A1 (0.39) | ALDH1A1GAANPSR1CASP1MAPT | |
| SCHEMBL6866888 | 0.86 | ALDH1A1 (0.39) | ALDH1A1GAANPSR1CASP1MAPT | |
| SCHEMBL29117803 | 0.81 | ALDH1A1 (0.47) | ALDH1A1GAAMAPTNPC1RAB9A | |
| SCHEMBL11030552 | 0.81 | CES2 (0.46) | ALDH1A1GAANPSR1CASP1MAPT | |
| SCHEMBL6871297 | 0.79 | ALDH1A1 (0.43) | ALDH1A1GAANPSR1CASP1MAPT | |
| SCHEMBL5996156 | 0.78 | SLC6A1 (0.31) | ALDH1A1GAAMAPTTSHRKMT2A | |
| SCHEMBL29117606 | 0.78 | ALDH1A1 (0.38) | ALDH1A1CES2CES1HSD11B1MEN1 | |
| SCHEMBL15442983 | 0.77 | ALDH1A1 (0.46) | ALDH1A1GAANPSR1CASP1MAPT | |
| SCHEMBL634058 | 0.77 | ALDH1A1 (0.46) | ALDH1A1GAANPSR1CASP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1311470-B1 | UNSATURATED ESTERS AND THEIR USE IN FRAGRANCE AND FLAVOUR COMPOSITIONS | GIVAUDAN SA (CH) | 2004-11-03 | — | — | EP | disclosed |
| US-20040023839-A1 | Unsaturated esters and their use in fragance and flavour compositions | GIVAUDAN SA (CH) | 2004-02-05 | — | — | US | disclosed |
| EP-1311470-A1 | UNSATURATED ESTERS AND THEIR USE IN FRAGRANCE AND FLAVOUR COMPOSITIONS | Givaudan SA (CH) | 2003-05-21 | — | — | EP | disclosed |
| WO-2002016307-A1 | UNSATURATED ESTERS AND THEIR USE IN FRAGRANCE AND FLAVOUR COMPOSITIONS | GIVAUDAN SA (CH) | 2002-02-28 | — | — | WO | disclosed |
| EP-1182190-A1 | Unsaturated esters | Givaudan SA (CH) | 2002-02-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040023839-A1 | Unsaturated esters and their use in fragance and flavour compositions | ELOVL5, FFAR3, ELOVL1 | ALDH1A1 472/4885GAA 1312/4885NPSR1 980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.